// App-Quantinova.ai

OC 54.1 : Rivaroxaban or placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer

Researchers

Presenter

  • C. Becattini

Principal Investigators

  • G. Avruscio

  • R. De Luca

  • F. Guerra

  • M. Righini

  • F. Dentali

  • G. Gussoni

  • G. Agnelli

Medical Centers

  • University of Perugia, Italy, Perugia, Umbria, Italy

  • National Cancer Institute, "G. Pascale" Foundation, Napoli, Napoli, Campania, Italy

  • Department of General Surgery, Santa Maria delle Grazie Hospital, Pozzuoli, Pozzuoli, Campania, Italy

  • Oncology Surgery, University of Perugia, Perugia, Perugia, Umbria, Italy

  • University Hospital of Padua, Padua, Padova, Veneto, Italy

  • S. Giovanni Battista Hospital, Foligno, Foligno, Umbria, Italy

  • General Surgery, S. Maria della Misericordia Hospital, Perugia, Perugia, Umbria, Italy

  • , Istituto Clinico Humanitas Mater Domini, Castellanza, Varese, Castellanza, Lombardia, Italy

  • General Surgery, S. Donato Hospital, Arezzo, Arezzo, Toscana, Italy

  • Vascular Medicine, S.Giacomo Apostolo Hospital, Catelfranco Veneto, Treviso, Treviso, Veneto, Italy

  • Surgical Oncology IRCCS Istituto Tumori " Giovanni Paolo II, Bari, Bari, Puglia, Italy

  • General Surgery, Ospedali Riuniti Marche Nord – Pesaro, Pesaro, Marche, Italy

  • General Surgery, E. Agnelli Hospital – Pinerolo, Pinerolo, Piemonte, Italy

  • General Surgery, Cittadella Hospital, AULSS 6 Euganea, Cittadella, Veneto, Italy

  • Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

  • Research Department, FADOI Foundation, Milan, Milano, Lombardia, Italy

  • ASST “Sette Laghi”, Insubria University, Varese, Varese, Lombardia, Italy

  • University of Perugia, Italy, Perugia, Umbria, Italy

Locations

  • Italy

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Superiority

  • Controlled

Phase

  • NA

Study Id's

  • NCT03055026

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved